Found 522 hits.
|
447. |
Spindler, M., Przybylowicz, K., Hawro, M., Weller, K., Reidel, U., Metz, M., Maurer, M., and Hawro, T.+: Sleep disturbance in adult dermatological patients: a cross-sectional study on prevalence, burden and associated factors. J. Am. Acad. Dermatol. 2021: 85; 910-922. IF: 15.49 |
o.447
| 118 | Luckey, U., Maurer, M., Schmidt, T., Lorenz, N., Seebach, B., Metz, M., and Steinbrink, K.+: T cell killing by tolerogenic dendritic cells protects from allergy in mice. J. Clin. Invest. 2011: 121; 3860-3871. IF: 13.06 |
o.118
|
195. |
Kolkhir, P.+, Grad, D. A., Charalampous, P., Cruz Oliveira, C., Mechili, E. A., Unim, B., Pearce, D. A., Maurer, M., Devleesschauwer, B., and Haagsma, J.: An EU task force to assess the burden of rare diseases. Nat. Medicine 2023: 29; 516-517. IF: 58.70 |
r.195
|
536. |
Church, M. K.+, Canonica, G. W., Kuna, P., Maurer, M., Mösges, R., Novak, Z., Papadopoulos, N. G., Rodriguez del Rio, P., and the Delphi Study Group: An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options. Expert Rev. Clin. Immunol. 2023: 19; 813-820. IF: 3.90 |
o.536
|
469. |
Giménez-Arnau, A.+, Maurer, M., Bernstein, J. A., Staubach, P., Barbier, N., Hua, E., Severin, T., Joubert, Y., Janocha, R., and Balp, M.-M.: Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria. Clin. Transl. Allergy 2022: 12; e12121. IF: 4.40 |
o.469
| 46 | Maurer, M. Lopez Kostka, S., Siebenhaar, F., Moelle, K., Metz, M., Knop, J., and von Stebut, E.+: Skin mast cells control T cell-dependent host defence in Leishmania major infections. FASEB J. 2006: 20; 2460-2467. IF: 6.72 |
| 319 | Siebenhaar, F.+, Sander, B., Ho, L. H. T., Ellrich, A., Maurer, M. and Weller, K.: Development and validation of the mastocytosis activity score. Allergy 2018: 73; 1489-1496. IF: 6.77 |
| 106. | Schmetzer, O., Valentin, P., Church, M. K., Maurer, M., and Siebenhaar, F.: Murine and human mast cell progenitors. Eur. J. Pharmacol. 2016: 778; 2-10. IF: 2.89 |
r.106
| 133 | Hepworth, M. R.+, Danilowicz-Luebert, E., Rausch, S., Metz, M., Klotz, C., Maurer, M. and Hartmann, S.: Mast cells orchestrate type 2 immunity to helminths through regulation of tissue derived cytokines. P. Natl. Acad. Sci. USA 2012: 109; 6644-6649. IF: 9.73 |